Polyethylene Glycol (PEG) is an ingredient in many products.  70% of the US population has antibodies to PEG.  The FDA classifies PEG as biologically inactive/inert. It is a key ingredient in vaccines to combat Covid 19, mRNA1273 made by Moderna and the Phizer vaccine.

This substance will kill me in about one minute.  So a vaccine that we are spending half a billion dollars on to complete trials and promote fielding promotes an immune response in the vast majority of the population.

This is the definition of insanity.

The government has stated they are instituting a study to identify the causes of higher than expected anaphylaxis cases in these vaccines, but the study excludes the examination of the most likely cause - PEG.

Steps to take:

70% of our population has antibodies to Moderna’s and Phizer’s SARS COV2 vaccine.

       Review clinical trial procedures to ensure this is taken account of to ensure vaccine effectiveness and safety.  Further trials will be necessary before final licensure.

       Reevaluate tax dollars allocated to the rapid trial and vaccine production of a product to deal with a worldwide health crisis known to have immunogenic properties in 70% of the population, even before trials.  As a note, our government has already spent (or allocated) half a billion to support rapid trial and manufacture of this vaccine.

Polyethylene Glycol, the constituent of this vaccine to which 70% of our population has antibodies, is considered biologically inert/inactive by our FDA.

       Reclassify Polyethtlene Glycol as biologically active and remove its designation as generally regarded as safe and biocompatible.

       Require a standard naming convention for Polyethylene Glycol in products.

       Require all products to list the presence of Polyethylene Glycol on product labels and product package inserts.

Most are unaware of this issue, leading to many unattributed adverse events due to Polyethylene Glycol.

       Widely publicize the national health risks of Polyethylene Glycol.

The CDC’s own tracking system, VAERS, has recorded approximately 55,000 cases of post vaccination anaphylaxis.  Additionally, it has recoded approximately 4434 post vaccination deaths.  A Mass Brigham General hospital study found 2.1 % of study participants had acute allergic reactions to the vaccines.  The impact on vaccine efficacy of preexisting antibodies to the vaccine itself are poorly understood, but it does not take a rocket scientist to understand that giving a population level vaccine to address a pandemic to which 72% of the population are allergic is a bad idea.